VR Logo

Harrow Health Inc. (HROW) download report


Healthcare | Drugs & Pharma

Harrow Health Inc. (HROW) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business.

IPO Date: 28-Sep-2007

CEO & Chairman: Mr. Mark L. Baum J.D.

CFO & Corp. Sec.: Mr. Andrew R. Boll C.F.A., C.M.A., CFA, CMA

Listing: NASDAQ: HROW

Country: United States

Headquarters: Nashville, TN

Website: https://www.harrowinc.com

Key Facts

Market cap: $193.00 Mln

Revenue (TTM): $6.75 Mln

Earnings (TTM): $-21.13 Mln

Cash: $50.59 Mln

Total Debt: $79.13 Mln

Insider's Holding: 8.02%

Liquidity: Low

52 Week range: $5.40 - 12.99

Shares outstanding: 27,031,100

10 Years Aggregate:

  • CFO: $-38.94 Mln
  • EBITDA: $-46.41 Mln
  • Net Profit: $-58.70 Mln

Stock Performance

Time Period Harrow Health (HROW) S&P BSE Healthcare S&P Small-Cap 600
YTD-17.36-17.04-18.78
1 month5.00-3.24-8.00
3 months4.69-10.55-13.65
1 Year-23.14-15.04-17.19
3 Years-6.3719.036.10
5 Years17.418.915.87
10 Years9.0612.199.84
As on 01-Jul-2022
Year Harrow Health (HROW) S&P Small-Cap 600 S&P BSE Healthcare
202125.9525.2720.87
2020-11.839.5761.45
201936.7320.86-3.55
2018232.51-9.70-5.89
2017-32.0011.730.49
2016-63.9224.74-12.88
2015-7.60-3.3615.06